Adjunct treatment with ketamine enhances the therapeutic effects of extinction learning after chronic unpredictable stress
- PMID: 35865972
- PMCID: PMC9293662
- DOI: 10.1016/j.ynstr.2022.100468
Adjunct treatment with ketamine enhances the therapeutic effects of extinction learning after chronic unpredictable stress
Abstract
Post-traumatic stress disorder (PTSD) is a debilitating illness characterized by dysfunction in the medial prefrontal cortex (mPFC). Although both pharmacological and cognitive behavioral interventions have shown some promise at alleviating symptoms, high attrition and persistence of treatment-resistant symptoms pose significant challenges that remain unresolved. Specifically, prolonged exposure therapy, a gold standard intervention to treat PTSD, has high dropout rates resulting in many patients receiving less than a fully effective course of treatment. Administering pharmacological treatments together with behavioral psychotherapies like prolonged exposure may offer an important avenue for enhancing therapeutic efficacy sooner, thus reducing the duration of treatment and mitigating the impact of attrition. In this study, using extinction learning as a rat model of exposure therapy, we hypothesized that administering ketamine as an adjunct treatment together with extinction will enhance the efficacy of extinction in reversing stress-induced deficits in set shifting, a measure of cognitive flexibility. Results showed that combining a sub-effective dose of ketamine with a shortened, sub-effective extinction protocol fully reversed stress-induced cognitive set-shifting deficits in both male and female rats. These effects may be due to shared molecular mechanisms between extinction and ketamine, such as increased neuronal plasticity in common circuitry (e.g., hippocampus-mPFC), or increased BDNF signaling. This work suggests that fast-acting drugs, such as ketamine, can be effectively used in combination with behavioral interventions to reduce treatment duration and potentially mitigate the impact of attrition. Future work is needed to delineate other pharmacotherapies that may complement the effects of extinction via shared or independent mechanisms.
Keywords: Adjunct treatment; Chronic stress; Fear extinction; Ketamine; Set shifting.
© 2022 The Authors.
Conflict of interest statement
Dr. Paredes, Mrs. Knippenberg, Dr. Bulin and Mrs. Keppler have no competing interests. Dr. Morilak receives in-kind research support from 10.13039/501100013327Lundbeck that has no relation to the work presented in this paper.
Figures




Similar articles
-
Activity in the Ventral Medial Prefrontal Cortex Is Necessary for the Therapeutic Effects of Extinction in Rats.J Neurosci. 2018 Feb 7;38(6):1408-1417. doi: 10.1523/JNEUROSCI.0635-17.2017. Epub 2018 Jan 15. J Neurosci. 2018. PMID: 29335360 Free PMC article.
-
Therapeutic Effects of Extinction Learning as a Model of Exposure Therapy in Rats.Neuropsychopharmacology. 2016 Dec;41(13):3092-3102. doi: 10.1038/npp.2016.127. Epub 2016 Jul 15. Neuropsychopharmacology. 2016. PMID: 27417516 Free PMC article.
-
Co-treatment of piracetam with risperidone rescued extinction deficits in experimental paradigms of post-traumatic stress disorder by restoring the physiological alterations in cortex and hippocampus.Pharmacol Biochem Behav. 2019 Oct;185:172763. doi: 10.1016/j.pbb.2019.172763. Epub 2019 Aug 22. Pharmacol Biochem Behav. 2019. PMID: 31445955
-
A Rodent Model of Exposure Therapy: The Use of Fear Extinction as a Therapeutic Intervention for PTSD.Front Behav Neurosci. 2019 Mar 11;13:46. doi: 10.3389/fnbeh.2019.00046. eCollection 2019. Front Behav Neurosci. 2019. PMID: 30914932 Free PMC article. Review.
-
Effects of ketamine on fear memory extinction: a review of preclinical literature.Front Neurosci. 2025 Apr 30;19:1546460. doi: 10.3389/fnins.2025.1546460. eCollection 2025. Front Neurosci. 2025. PMID: 40370666 Free PMC article.
Cited by
-
Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD.Psychopharmacology (Berl). 2025 Jun;242(6):1197-1243. doi: 10.1007/s00213-025-06756-4. Epub 2025 Mar 17. Psychopharmacology (Berl). 2025. PMID: 40097854 Free PMC article.
-
Ketamine's Amelioration of Fear Extinction in Adolescent Male Mice Is Associated with the Activation of the Hippocampal Akt-mTOR-GluA1 Pathway.Pharmaceuticals (Basel). 2024 May 22;17(6):669. doi: 10.3390/ph17060669. Pharmaceuticals (Basel). 2024. PMID: 38931336 Free PMC article.
-
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder.Neuropharmacology. 2023 Mar 15;226:109418. doi: 10.1016/j.neuropharm.2023.109418. Epub 2023 Jan 6. Neuropharmacology. 2023. PMID: 36623804 Free PMC article. Review.
-
Rat Models in Post-Traumatic Stress Disorder Research: Strengths, Limitations, and Implications for Translational Studies.Pathophysiology. 2024 Dec 6;31(4):709-760. doi: 10.3390/pathophysiology31040051. Pathophysiology. 2024. PMID: 39728686 Free PMC article. Review.
-
Cerebral hemodynamic characteristics of patients with auditory verbal hallucinations and the construction of nomogram models.World J Psychiatry. 2025 Jun 19;15(6):106775. doi: 10.5498/wjp.v15.i6.106775. eCollection 2025 Jun 19. World J Psychiatry. 2025. PMID: 40574762 Free PMC article.
References
-
- Bernardy N.C., Friedman M.J. Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned? Curr. Psychiatr. Rep. 2015;17(4):20. - PubMed
-
- Bernhardt M., Schwert C., Aschenbrenner S., Weisbrod M., Schröder A. Longitudinal changes of cognitive deficits and treatment outcome of cognitive behavioral therapy for major depression. J. Nerv. Ment. Dis. 2021;209(5):336–342. - PubMed
-
- Block A.E., Dhanji H., Thompson-Tardif S.F., Floresco S.B. Thalamic–prefrontal cortical–ventral striatal circuitry mediates dissociable components of strategy set shifting. Cerebr. Cortex. 2007;17(7):1625–1636. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources